Loading…

Molecular MRD Assessment Is Strongly Prognostic in Patients with NPM1 Mutated AML Receiving Venetoclax Based Non-Intensive Therapy

Saved in:

Bibliographic Details
Published in:	Blood 2022-11, Vol.140 (Supplement 1), p.2033-2035
Main Authors:	Othman, Jad, Tiong, Ing S, Mokretar, Katya, Ivey, Adam, Austin, Michael James, Latif, Anne-Louise, Crawley, Charles, Amer, Mariam, Crolla, Francesca, Cross, Joe W, Dang, Raymond, Fong, Chun Yew, Galli, Sofia, Gallipoli, Paolo, Hogan, Francesca L, Kalkur, Pallavi, Khan, Anjum, Krishnamurthy, Pramila, Laurie, John, Marshall, Scott R., Murthy, Vidhya, Nagumantry, Sateesh K., Pillai, Srinivas, Potter, Nicola, Taylor, Tom, Zhao, Rui, Wei, Andrew H, Dillon, Richard
Format:	Article
Language:	English
Citations:	Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!